RxDoctor Payments Data

Perry Sexton, MD

Family Medicine · Encinitas, CANPI 1972665339

Payments from drug & device makers

$5,585in general payments, 2019–2025

Across 299 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Indivior Inc.$684
  • Supernus Pharmaceuticals, Inc.$429
  • Novo Nordisk$406
  • Takeda Pharmaceuticals U.S.A., Inc.$273
  • Alkermes, Inc.$180
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,585100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,585 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$198,395
Medicare patients
315
Services billed
2,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide51$69,591
EliquisApixaban49$38,214
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl221$22,593
FarxigaDapagliflozin Propanediol20$16,803
SunosiSolriamfetol Hcl11$9,153
EntrestoSacubitril/Valsartan13$8,680
JardianceEmpagliflozin11$6,588
MovantikNaloxegol Oxalate16$6,549
Breo ElliptaFluticasone/Vilanterol14$5,697
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$5,660
SymbicortBudesonide/Formoterol Fumarate11$2,765
Wixela InhubFluticasone Propion/Salmeterol20$2,734
Buprenorphine Hcl71$2,700
SynthroidLevothyroxine Sodium28$2,311
Albuterol Sulfate HfaAlbuterol Sulfate69$2,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$406$69,59151 claims
PfizerEliquis, Paxlovid$163$39,64496 claims
Axsome Therapeutics, Inc.Sunosi$28$9,15311 claims
GSKBreo Ellipta$148$5,69714 claims
AbbVieSynthroid$1,508$2,31128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Encinitas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →